Precision Cancer Consortium announces new industry member and leadership succession as it celebrates its one-year anniversary
The Precision Cancer Consortium (PCC) is pleased to announce the addition of AstraZeneca as its newest member.
April 2023
2022, Year in Review
Precision Cancer Consortium is dedicated to making personalised medicine a reality by aligning health care stakeholders. Our review of 2022.
2022, Year in Review Read More »
